Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials / Florian Seemüller en The Journal of Clinical Psychiatry, Año 2010 - Vol. 71 - No. 11 (Noviembre)

Público ISBD [artículo]  inThe Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 11 (Noviembre) . - pp. 1425-1433 Título : Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials Tipo de documento: texto impreso Autores: Florian Seemüller, Autor ; Hans Jürgen Möller, Autor ; Michael Obermeier, Autor Fecha de publicación: 2022 Artículo en la página: pp. 1425-1433 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor, Estimación de Kaplan Meier, Selección de pacientes, Ensayos controlados aleatorios. Resumen: Because of strict inclusion and exclusion criteria, results drawn from placebo-controlled randomized antidepressant efficacy trials may not be transferable to real-world patients. Link: ./index.php?lvl=notice_display&id=28250 [artículo] Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials [texto impreso] / Florian Seemüller, Autor ; Hans Jürgen Möller, Autor ; Michael Obermeier, Autor . - 2022 . - pp. 1425-1433. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The Journal of Clinical Psychiatry > Año 2010 - Vol. 71 - No. 11 (Noviembre) . - pp. 1425-1433 Palabras clave: Antidepresivos, Trastorno depresivo mayor, Estimación de Kaplan Meier, Selección de pacientes, Ensayos controlados aleatorios. Resumen: Because of strict inclusion and exclusion criteria, results drawn from placebo-controlled randomized antidepressant efficacy trials may not be transferable to real-world patients. Link: ./index.php?lvl=notice_display&id=28250

Effects of different antidepressant treatments on the core of depression / Thomas C. Baghai en Dialogues in Clinical Neuroscience, Año 2008 Vol.10 - No.3 (Septiembre)

Público ISBD [artículo]  inDialogues in Clinical Neuroscience > Año 2008 Vol.10 - No.3 (Septiembre) . - pp. 309–320 Título : Effects of different antidepressant treatments on the core of depression Tipo de documento: texto impreso Autores: Thomas C. Baghai, Autor ; Daniela Eser, Autor ; Hans Jürgen Möller, Autor Fecha de publicación: 2022 Artículo en la página: pp. 309–320 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Tratamiento antidepresivo, Depresión, Melancolía, Tratamiento farmacológico, Terapia electroconvulsiva Resumen: Core symptoms of depression are a combination of psychological and somatic symptoms, often combined with psychomotor and cognitive disturbances. Diagnostic classification of depression including the concepts of melancholic, endogenous, or severe depression describe severely depressed patients suffering from most of the core symptoms, together with clinical characteristics of a cyclic unipolar or bipolar course,... Link: ./index.php?lvl=notice_display&id=28720 [artículo] Effects of different antidepressant treatments on the core of depression [texto impreso] / Thomas C. Baghai, Autor ; Daniela Eser, Autor ; Hans Jürgen Möller, Autor . - 2022 . - pp. 309–320. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Dialogues in Clinical Neuroscience > Año 2008 Vol.10 - No.3 (Septiembre) . - pp. 309–320 Palabras clave: Tratamiento antidepresivo, Depresión, Melancolía, Tratamiento farmacológico, Terapia electroconvulsiva Resumen: Core symptoms of depression are a combination of psychological and somatic symptoms, often combined with psychomotor and cognitive disturbances. Diagnostic classification of depression including the concepts of melancholic, endogenous, or severe depression describe severely depressed patients suffering from most of the core symptoms, together with clinical characteristics of a cyclic unipolar or bipolar course,... Link: ./index.php?lvl=notice_display&id=28720

Electroconvulsive therapy and its different indications / Thomas C. Baghai en Dialogues in Clinical Neuroscience, Año 2008 Vol.10 - No.1 (Marzo)

Público ISBD [artículo]  inDialogues in Clinical Neuroscience > Año 2008 Vol.10 - No.1 (Marzo) . - pp. 105–117 Título : Electroconvulsive therapy and its different indications Tipo de documento: texto impreso Autores: Thomas C. Baghai, Autor ; Hans Jürgen Möller, Autor Fecha de publicación: 2022 Artículo en la página: pp. 105–117 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Terapia electroconvulsiva, Resistencia al tratamiento, Depresión, Esquizofrenia Resumen: In spite of recent developments in the pharmacotherapy of depressive disorders, the delay until clinical improvement can be achieved, and the considerable rate of nonresponse and nonremission, are major problems which remain unresolved. Link: ./index.php?lvl=notice_display&id=28702 [artículo] Electroconvulsive therapy and its different indications [texto impreso] / Thomas C. Baghai, Autor ; Hans Jürgen Möller, Autor . - 2022 . - pp. 105–117. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Dialogues in Clinical Neuroscience > Año 2008 Vol.10 - No.1 (Marzo) . - pp. 105–117 Palabras clave: Terapia electroconvulsiva, Resistencia al tratamiento, Depresión, Esquizofrenia Resumen: In spite of recent developments in the pharmacotherapy of depressive disorders, the delay until clinical improvement can be achieved, and the considerable rate of nonresponse and nonremission, are major problems which remain unresolved. Link: ./index.php?lvl=notice_display&id=28702

Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group / Hans Jürgen Möller en Journal of Clinical Psychopharmacology, Año 2001 - Vol. 21 - No. 1 (Febrero)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 59-65 Título : Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group Tipo de documento: texto impreso Autores: Hans Jürgen Möller, Autor ; Hans Peter Volz, Autor ; Ingrid W. Reimann, Autor Fecha de publicación: 2023 Artículo en la página: pp. 59-65 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alprazolam, Ansiolíticos, Antidepresivos, Trastornos de ansiedad, Opipramol. Resumen: Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has pronounced D2-, 5-HT2-, and H1-blocking potential and high affinity to sigma receptors (sigma-1 and sigma-2). In early controlled trials, anxiolytic effects were revealed. However, those studies were performed before the concept of generalized anxiety disorder (GAD) was established. Link: ./index.php?lvl=notice_display&id=31138 [artículo] Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group [texto impreso] / Hans Jürgen Möller, Autor ; Hans Peter Volz, Autor ; Ingrid W. Reimann, Autor . - 2023 . - pp. 59-65. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 1 (Febrero) . - pp. 59-65 Palabras clave: Alprazolam, Ansiolíticos, Antidepresivos, Trastornos de ansiedad, Opipramol. Resumen: Opipramol, a drug widely prescribed in Germany, is a tricyclic compound with no reuptake-inhibiting properties. However, it has pronounced D2-, 5-HT2-, and H1-blocking potential and high affinity to sigma receptors (sigma-1 and sigma-2). In early controlled trials, anxiolytic effects were revealed. However, those studies were performed before the concept of generalized anxiety disorder (GAD) was established. Link: ./index.php?lvl=notice_display&id=31138

A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature / Joseph Zohar en European Neuropsychopharmacology, Año 2015 - Vol. 25 - No.12 (Diciembre)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2015 - Vol. 25 - No.12 (Diciembre) . - pp. 2318-2325 Título : A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature Tipo de documento: texto impreso Autores: Joseph Zohar, Autor ; Stephen M. Stahl, Autor ; Hans Jürgen Möller, Autor Fecha de publicación: 2021 Artículo en la página: pp. 2318-2325 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Drogas psicotropicas, Nomenclatura, Dominio farmacológico, Modo de acción, Neurociencia, Adherencia Resumen: Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. Link: ./index.php?lvl=notice_display&id=26658 [artículo] A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature [texto impreso] / Joseph Zohar, Autor ; Stephen M. Stahl, Autor ; Hans Jürgen Möller, Autor . - 2021 . - pp. 2318-2325. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2015 - Vol. 25 - No.12 (Diciembre) . - pp. 2318-2325 Palabras clave: Drogas psicotropicas, Nomenclatura, Dominio farmacológico, Modo de acción, Neurociencia, Adherencia Resumen: Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. Link: ./index.php?lvl=notice_display&id=26658

The University Department of Psychiatry in Munich / Hanns Hippius ; Hans Jürgen Möller

Permalink

---

1 (1 - 6 / 6)